![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Essential Innovations Technology Corporation (CE) | USOTC:ESIV | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0001 | 0.00 | 01:00:00 |
þ
|
Yes
|
o
|
No
|
þ
|
Yes
|
o
|
No
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
þ
|
o
|
Yes
|
þ
|
No
|
ESSENTIAL INNOVATIONS TECHNOLOGY CORP
|
||||||||
(a development stage enterprise)
|
||||||||
Balance Sheets
|
||||||||
April 30, 2014 and October 31, 2013
|
||||||||
(unaudited)
|
||||||||
April 30,
|
October 31,
|
|||||||
2014
|
2013
|
|||||||
Assets
|
||||||||
Current assets:
|
||||||||
Cash
|
$ | - | $ | 82,424 | ||||
Total current assets
|
- | 82,424 | ||||||
Total assets
|
$ | - | $ | 82,424 | ||||
Liabilities and Stockholders' Deficiency
|
||||||||
Current liabilities:
|
||||||||
Bank overdraft
|
$ | 48 | $ | - | ||||
Accounts payable
|
404,005 | 372,872 | ||||||
Accrued expenses
|
77,500 | 82,500 | ||||||
Accrued compensation
|
34,033 | 10,000 | ||||||
Amounts due to stockholders
|
47,538 | 49,570 | ||||||
Current portion of long term debt
|
491,299 | 491,299 | ||||||
Total current liabilities
|
1,054,423 | 1,006,241 | ||||||
Stockholders' Deficiency
|
||||||||
Preferred stock:
|
||||||||
$0.001 par value, authorized 10,000,000 shares,
|
||||||||
issued and outstanding nil shares (2013 - nil)
|
- | - | ||||||
Common stock:
|
||||||||
$0.001 par value, authorized 500,000,000 shares,
|
||||||||
issued and outstanding 23,452,445 shares (2013 - 23,452,445)
|
23,453 | 23,453 | ||||||
Additional paid-in capital
|
3,186,940 | 3,186,940 | ||||||
Accumulated deficit
|
(1,849,309 | ) | (1,849,309 | ) | ||||
Deficit accumulated during development stage
|
(2,415,507 | ) | (2,284,901 | ) | ||||
Total stockholders' deficiency
|
(1,054,423 | ) | (923,817 | ) | ||||
Total liabilities and stockholders' deficiency
|
$ | - | $ | 82,424 |
ESSENTIAL INNOVATIONS TECHNOLOGY CORP
|
||||||||||||||||||||
(a development stage enterprise)
|
||||||||||||||||||||
Statements of Operations
|
||||||||||||||||||||
For the Three and Six Months Ended April 30, 2014 and 2013 and for the period
|
||||||||||||||||||||
from commencement of development stage, November 1, 2009,
|
||||||||||||||||||||
to April 30, 2014
|
||||||||||||||||||||
(unaudited)
|
||||||||||||||||||||
Three Months Ended April 30
|
Six Months Ended April 30
|
cumulative from commencement of development stage, November
|
||||||||||||||||||
2014
|
2013
|
2014
|
2013
|
1, 2009, to April 30, 2014 | ||||||||||||||||
Revenue
|
$ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||
Expenses:
|
||||||||||||||||||||
General and administrative
|
73,857 | 67,694 | 118,044 | 147,330 | 861,553 | |||||||||||||||
Marketing
|
- | - | - | 1,280,838 | ||||||||||||||||
Impairment loss
|
- | - | - | - | 260,068 | |||||||||||||||
Total operating expenses
|
73,857 | 67,694 | 118,044 | 147,330 | 2,402,459 | |||||||||||||||
Loss from operations
|
(73,857 | ) | (67,694 | ) | (118,044 | ) | (147,330 | ) | (2,402,459 | ) | ||||||||||
Interest expense
|
(6,177 | ) | (6,200 | ) | (12,562 | ) | (12,643 | ) | (115,341 | ) | ||||||||||
Gain on debt forgiveness
|
- | - | - | - | 102,293 | |||||||||||||||
Net Loss
|
$ | (80,034 | ) | (73,894 | ) | $ | (130,606 | ) | $ | (159,973 | ) | $ | (2,415,507 | ) | ||||||
Net loss per share
|
||||||||||||||||||||
Basic and diluted net loss per share
|
$ | (0.00 | ) | $ | (0.00 | ) | $ | (0.01 | ) | $ | (0.01 | ) | ||||||||
Weighted average number of shares outstanding
|
||||||||||||||||||||
Basic and diluted
|
23,452,445 | 17,332,445 | 23,452,445 | 17,332,445 |
Exhibit Number*
|
Title of Document
|
Location
|
||
Item 31
|
Rule 13a-14(a)/15d-14(a) Certifications
|
|||
31.01
|
Certification of Principal Executive Officer and Principal Financial Officer
Pursuant to Rule 13a-14
|
Attached
|
||
Item 32
|
Section 1350 Certifications
|
|||
32.01
|
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Chief Executive Officer) and (Chief Financial Officer)
|
Attached
|
||
Item 101
|
Interactive Data File
|
|||
101
|
Interactive Data File
|
Attached
|
*
|
All exhibits are numbered with the number preceding the decimal indicating the applicable SEC reference number in Item 601 and the number following the decimal indicating the sequence of the particular document.
|
Registrant
|
||
ESSENTIAL INNOVATIONS TECHNOLOGY CORP.
|
||
Date: June 16, 2014
|
By:
|
/s/ JASONMCDIARMID
|
Jason McDiarmid
|
||
President, Chief Executive Officer, Chief Financial Officer, Treasurer and Director
|
||
(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)
|
||
1 Year Essential Innovations Te... (CE) Chart |
1 Month Essential Innovations Te... (CE) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions